Rabea Wagener

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 8

Top Topics

Autism Spectrum Disorder

Dna Damage Response

Patient Reported

Tyrosine Kinase

Top Venues

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Arndt Borkhardt, Rabea Wagener, Triantafyllia Brozou
Reply to: Comments on "The CHK2 kinase is recurrently mutated and functionally impaired in the germline of pediatric cancer patients". International journal of cancer 152 (9) (2023)
Arndt Borkhardt, Rabea Wagener, Triantafyllia Brozou
Reply to: Comments on the CHK2 kinase is recurrently mutated and functionally impaired in the germline of pediatric cancer patients. International journal of cancer (2023)
Arndt Borkhardt, Rabea Wagener, Triantafyllia Brozou
Reply to: Comments on "The CHK2 kinase is recurrently mutated and functionally impaired in the germline of pediatric cancer patients". International journal of cancer 152 (9) (2023)
Rabea Wagener, Danielle Brandes, Marie Jung, Maxim A Huetzen, Anke K Bergmann, Stephanie Panier, Daniel Picard, Ute Fischer, Ron D Jachimowicz, Arndt Borkhardt, Triantafyllia Brozou
Optical genome mapping identifies structural variants in potentially new cancer predisposition candidate genes in pediatric cancer patients. International journal of cancer (2023)
Arndt Borkhardt, Rabea Wagener, Triantafyllia Brozou
Reply to: Comments on < The CHK2 kinase is recurrently mutated and functionally impaired in the germline of pediatric cancer patients>. International journal of cancer (2023)
Arndt Borkhardt, Rabea Wagener, Triantafyllia Brozou
Reply to: Comments on "The CHK2 kinase is recurrently mutated and functionally impaired in the germline of pediatric cancer patients". International journal of cancer 152 (9) (2023)
Arndt Borkhardt, Rabea Wagener, Triantafyllia Brozou
Reply to: Comments on "The CHK2 kinase is recurrently mutated and functionally impaired in the germline of pediatric cancer patients". International journal of cancer 152 (9) (2023)
Rabea Wagener, Carolin Walter, Franziska Auer, Deya Alzoubi, Julia Hauer, Ute Fischer, Julian Varghese, Martin Dugas, Arndt Borkhardt, Triantafyllia Brozou
The CHK2 kinase is recurrently mutated and functionally impaired in the germline of pediatric cancer patients. International journal of cancer (2022)